![William Quinn](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
William Quinn
Directeur Général chez
BOLT BIOTHERAPEUTICS, INC.
Fortune : 12 143 $ au 31/05/2026
Profil
William P.
Quinn was the founder of Bullet Biotechnology, Inc., founded in 2011, where the titles held included President, Chief Executive Officer & Director from 2011 to 2017.
Current jobs include President, Chief Executive Officer, CFO & Director at Bolt Biotherapeutics, Inc. since 2024, and Director at Solar Roof Dynamics LLC since 2017.
Former jobs include Director at Midnight Pharmaceuticals, Inc. from 2013 to 2019; Director at Neurogastrx, Inc. from 2012 to 2017; Director at A Foundation Building Strength For Nemaline Myopathy from 2011 to 2021; CFO, Senior VP-Finance & Corporate Development at Sunesis Pharmaceuticals, Inc. from 2017 to 2020; Head-Corporate Development at Jazz Pharmaceuticals, Inc. from 2003 to 2011; Chief Financial & Operating Officer at Novation Biosciences, Inc. from 2001 to 2002; and Associate Partner at MFVC, Inc. from 1999 to 2001.
Education includes undergraduate and graduate degrees from Stanford University and an MBA from Stanford Graduate School of Business.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/03/2026 | 2 313 ( 0,12% ) | 12 143 $ | 31/05/2026 |
Postes actifs de William Quinn
| Sociétés | Poste | Début |
|---|---|---|
| BOLT BIOTHERAPEUTICS, INC. | Directeur Général | 15/05/2024 |
Solar Roof Dynamics LLC
 Solar Roof Dynamics LLC Wholesale DistributorsDistribution Services Wholesales electrical apparatus and equipment and repairs personal use appliance | Directeur/Membre du Conseil | 01/11/2017 |
Anciens postes connus de William Quinn
| Sociétés | Poste | Fin |
|---|---|---|
A Foundation Building Strength For Nemaline Myopathy
 A Foundation Building Strength For Nemaline Myopathy Miscellaneous Commercial ServicesCommercial Services A Foundation Building Strength For Nemaline Myopathy is a nonprofit organization dedicated to advancing research and developing treatments for nemaline myopathy, a rare genetic muscle disorder that affects movement, speech, swallowing, and breathing. The private company is based in Palo Alto. The organization unites patients, caregivers, scientists, and clinicians to build research infrastructure such as registries, tissue repositories, animal models, and natural history studies, and accelerates translational research from basic science to clinical trials. It funds research projects focusing on gene therapies, drug repurposing, patient-derived cell models, and therapeutic strategies targeting mutations in key genes related to nemaline myopathy. The foundation also supports studies on disease mechanisms, muscle metabolism, and function, and promotes the development of assistive technologies. Additional services include free genetic testing, biobanking, advocacy for accurate medical coding, and comprehensive resources and support for the nemaline myopathy community, such as care guides, support groups, events, and educational materials. | Directeur/Membre du Conseil | 01/01/2021 |
| VIRACTA THERAPEUTICS, INC. | Directeur Financier/CFO | 01/05/2020 |
Midnight Pharmaceuticals, Inc.
 Midnight Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops novel product for the treatment of insomnia | Directeur/Membre du Conseil | 01/02/2019 |
Neurogastrx, Inc.
 Neurogastrx, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops transformative therapies for gastrointestinal disorders | Directeur/Membre du Conseil | 01/12/2017 |
Bullet Biotechnology, Inc.
 Bullet Biotechnology, Inc. BiotechnologyHealth Technology Develops immunotherapy products | Fondateur | 01/11/2017 |
Formation de William Quinn
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
44
Relations au 1er degré
12
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 12 |
|---|---|
Jazz Pharmaceuticals, Inc.
 Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products | Health Technology |
Sunesis Pharmaceuticals, Inc.
 Sunesis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology therapeutics for treatment of solid and hematologic cancers | Health Technology |
Bullet Biotechnology, Inc.
Bullet Biotechnology, Inc. BiotechnologyHealth Technology Develops immunotherapy products | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MFVC, Inc.
 MFVC, Inc. Investment ManagersFinance Mobius Venture Capital invests in companies located in the United States. The firm focuses on a broad range of sectors and industries. It provides financing for early-stage capital requirements. | Finance |
Novation Biosciences, Inc. | |
Stanford Graduate School of Business
 Stanford Graduate School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bolt Biotherapeutics, Inc.
 Bolt Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage immuno-oncology company | Health Technology |
Neurogastrx, Inc.
Neurogastrx, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops transformative therapies for gastrointestinal disorders | Health Technology |
Solar Roof Dynamics LLC
Solar Roof Dynamics LLC Wholesale DistributorsDistribution Services Wholesales electrical apparatus and equipment and repairs personal use appliance | Distribution Services |
Midnight Pharmaceuticals, Inc.
Midnight Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops novel product for the treatment of insomnia | Health Technology |
A Foundation Building Strength For Nemaline Myopathy
A Foundation Building Strength For Nemaline Myopathy Miscellaneous Commercial ServicesCommercial Services A Foundation Building Strength For Nemaline Myopathy is a nonprofit organization dedicated to advancing research and developing treatments for nemaline myopathy, a rare genetic muscle disorder that affects movement, speech, swallowing, and breathing. The private company is based in Palo Alto. The organization unites patients, caregivers, scientists, and clinicians to build research infrastructure such as registries, tissue repositories, animal models, and natural history studies, and accelerates translational research from basic science to clinical trials. It funds research projects focusing on gene therapies, drug repurposing, patient-derived cell models, and therapeutic strategies targeting mutations in key genes related to nemaline myopathy. The foundation also supports studies on disease mechanisms, muscle metabolism, and function, and promotes the development of assistive technologies. Additional services include free genetic testing, biobanking, advocacy for accurate medical coding, and comprehensive resources and support for the nemaline myopathy community, such as care guides, support groups, events, and educational materials. | Commercial Services |
Choisissez Zonebourse 
